Despite the high relevance of secreted Wnt ligands in different cancers and the reported additional Wnt‐independent functions of Porcn (Covey et al, 2012; Erlenhardt et al, 2016), inhibition of Porcn is to date the only pharmacological approach to inhibit Wnt secretion. The gene discussed is PORCN; the disease is cancer.